<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33257786</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>20862</StartPage><MedlinePgn>20862</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20862</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-77564-3</ELocationID><Abstract><AbstractText>Inflammatory signaling is thought to modulate the neurodegenerative cascade in amyotrophic lateral sclerosis (ALS). We have previously shown that expression of Interleukin-10 (IL-10), a classical anti-inflammatory cytokine, extends lifespan in the SOD1-G93A mouse model of familial ALS. Here we test whether co-expression of the decoy chemokine receptor M3, that can scavenge inflammatory chemokines, augments the efficacy of IL-10. We found that recombinant adeno-associated virus (AAV)-mediated expression of IL-10, alone, or in combination with M3, resulted in modest extension of lifespan relative to control SOD1-G93A cohort. Interestingly neither AAV-M3 alone nor AAV-IL-10 + AAV-M3&#xa0;extend survival beyond that of the AAV-IL-10 alone cohort. Focused transcriptomic analysis revealed induction of innate immunity and phagocytotic pathways in presymptomatic SOD1-G93A mice expressing IL-10&#x2009;+&#x2009;M3 or IL-10 alone. Further, while IL-10 expression increased microglial burden, the IL-10&#x2009;+&#x2009;M3 group showed lower microglial burden, suggesting that M3 can successfully lower microgliosis before disease onset. Our data demonstrates that over-expression of an anti-inflammatory cytokine and a decoy chemokine receptor can modulate inflammatory processes in SOD1-G93A mice, modestly delaying the age to paralysis. This suggests that multiple inflammatory pathways can be targeted simultaneously in neurodegenerative disease and supports consideration of adapting these approaches to treatment of ALS and related disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Washington University, St. Louis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibanez</LastName><ForeName>Kristen R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaroshenko</LastName><ForeName>Mariya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Carolina Ceballos</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borchelt</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, FL, 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarty</LastName><ForeName>Paramita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, 32610, USA. pchakrabarty@ufl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Florida, Gainesville, FL, 32610, USA. pchakrabarty@ufl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, FL, 32610, USA. pchakrabarty@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS092788</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C556062">IL10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2021 Feb 3;11(1):3396</RefSource><PMID Version="1">33536539</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>1</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33257786</ArticleId><ArticleId IdType="pmc">PMC7705692</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-77564-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-77564-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad.Sci. U.S.A. 2008;105:7594. doi: 10.1073/pnas.0802556105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Investig. 2017;127:3250. doi: 10.1172/JCI90607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, et al. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. Mol. Ther. 2015;23:53. doi: 10.1038/mt.2014.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.180</ArticleId><ArticleId IdType="pmc">PMC4426802</ArticleId><ArticleId IdType="pubmed">25228069</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122:3063. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav. Immun. 2011;25:1025. doi: 10.1016/j.bbi.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernaez B, Alcami A. Virus-encoded cytokine and chemokine decoy receptors. Curr. Opin. Immunol. 2020;66:50. doi: 10.1016/j.coi.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2020.04.008</ArticleId><ArticleId IdType="pubmed">32408109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes DJ, et al. Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host. PLoS Pathog. 2011;7:e1001321. doi: 10.1371/journal.ppat.1001321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001321</ArticleId><ArticleId IdType="pmc">PMC3060169</ArticleId><ArticleId IdType="pubmed">21445235</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JM, et al. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell. 2002;111:343. doi: 10.1016/S0092-8674(02)01007-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)01007-3</ArticleId><ArticleId IdType="pubmed">12419245</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander-Brett JM, Fremont DH. Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J. Exp. Med. 2007;204:3157. doi: 10.1084/jem.20071677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071677</ArticleId><ArticleId IdType="pmc">PMC2150966</ArticleId><ArticleId IdType="pubmed">18070938</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry CM, et al. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 2000;191:573. doi: 10.1084/jem.191.3.573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.3.573</ArticleId><ArticleId IdType="pmc">PMC2195820</ArticleId><ArticleId IdType="pubmed">10662803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen KK, et al. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J. Virol. 2003;77:624. doi: 10.1128/JVI.77.1.624-630.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.1.624-630.2003</ArticleId><ArticleId IdType="pmc">PMC140591</ArticleId><ArticleId IdType="pubmed">12477865</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran D, et al. Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice. PLoS ONE. 2017;12:e0173224. doi: 10.1371/journal.pone.0173224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173224</ArticleId><ArticleId IdType="pmc">PMC5345809</ArticleId><ArticleId IdType="pubmed">28282403</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin AP, et al. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Diabetes. 2008;57:387. doi: 10.2337/db07-1309.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1309</ArticleId><ArticleId IdType="pubmed">18003753</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarty P, et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS ONE. 2013;8:e67680. doi: 10.1371/journal.pone.0067680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067680</ArticleId><ArticleId IdType="pmc">PMC3692458</ArticleId><ArticleId IdType="pubmed">23825679</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, et al. Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotroph Lateral Scler. 2011;12:79. doi: 10.3109/17482968.2010.550626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.550626</ArticleId><ArticleId IdType="pubmed">21241159</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, et al. Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis. J Neurol Sci. 2005;236:1&#x2013;2. doi: 10.1016/j.jns.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarty P, et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron. 2015;85:519. doi: 10.1016/j.neuron.2014.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.11.020</ArticleId><ArticleId IdType="pmc">PMC4320003</ArticleId><ArticleId IdType="pubmed">25619653</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, et al. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Su XW, et al. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis. JAMA Neurol. 2013;70:1505.</Citation><ArticleIdList><ArticleId IdType="pubmed">24145899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel M, et al. IL-10 controls early microglial phenotypes and disease onset in ALS caused by misfolded superoxide dismutase 1. J. Neurosci. 2016;36:1031. doi: 10.1523/JNEUROSCI.0854-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0854-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu LT, Bowser R. Fluid-based biomarkers for amyotrophic lateral sclerosis. Neurotherapeutics. 2017;14:119. doi: 10.1007/s13311-016-0503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0503-x</ArticleId><ArticleId IdType="pmc">PMC5233638</ArticleId><ArticleId IdType="pubmed">27933485</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003;3:36. doi: 10.1038/nri980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri980</ArticleId><ArticleId IdType="pubmed">12511874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Motos V, Kropp KA, Viejo-Borbolla A. Chemokine binding proteins: an immunomodulatory strategy going viral. Cytokine Growth Factor Rev. 2016;30:71. doi: 10.1016/j.cytogfr.2016.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2016.02.007</ArticleId><ArticleId IdType="pubmed">26987612</ArticleId></ArticleIdList></Reference><Reference><Citation>van Berkel V, et al. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol. 2000;74:6741. doi: 10.1128/JVI.74.15.6741-6747.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.15.6741-6747.2000</ArticleId><ArticleId IdType="pmc">PMC112190</ArticleId><ArticleId IdType="pubmed">10888612</ArticleId></ArticleIdList></Reference><Reference><Citation>Fra AM, et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 2003;170:2279. doi: 10.4049/jimmunol.170.5.2279.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.5.2279</ArticleId><ArticleId IdType="pubmed">12594248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lira SA, et al. The chemokine-binding protein M3 as a tool to understand the chemokine network in vivo. Methods Enzymol. 2009;460:193. doi: 10.1016/S0076-6879(09)05209-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(09)05209-4</ArticleId><ArticleId IdType="pubmed">19446726</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyo R, et al. Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am. J. Pathol. 2004;164:2289. doi: 10.1016/S0002-9440(10)63785-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63785-6</ArticleId><ArticleId IdType="pmc">PMC1615775</ArticleId><ArticleId IdType="pubmed">15161661</ArticleId></ArticleIdList></Reference><Reference><Citation>Millward JM, et al. The murine gammaherpesvirus-68 chemokine-binding protein M3 inhibits experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010;224:45. doi: 10.1016/j.jneuroim.2010.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.05.005</ArticleId><ArticleId IdType="pubmed">20537410</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash KR, et al. Fractalkine over expression suppresses alpha-synuclein-mediated neurodegeneration. Mol. Ther. 2015;23:17. doi: 10.1038/mt.2014.175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.175</ArticleId><ArticleId IdType="pmc">PMC4426798</ArticleId><ArticleId IdType="pubmed">25195598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, et al. Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo. Eur. J. Neurosci. 2013;37:1203. doi: 10.1111/ejn.12126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.12126</ArticleId><ArticleId IdType="pmc">PMC3628093</ArticleId><ArticleId IdType="pubmed">23347239</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014;17:131. doi: 10.1038/nn.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3599</ArticleId><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler. 2008;9:4. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A, Lobsiger CS, Boillee S. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2019;32:764. doi: 10.1097/WCO.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000729</ArticleId><ArticleId IdType="pubmed">31306211</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeler AM, Flotte TR. Recombinant adeno-associated virus gene therapy in light of luxturna (and zolgensma and glybera): Where are we, and how did we get here? Annu. Rev. Virol. 2019;6:601. doi: 10.1146/annurev-virology-092818-015530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092818-015530</ArticleId><ArticleId IdType="pmc">PMC7123914</ArticleId><ArticleId IdType="pubmed">31283441</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, et al. Substantially elevating the levels of alphaB-crystallin in spinal motor neurons of mutant SOD1 mice does not significantly delay paralysis or attenuate mutant protein aggregation. J. Neurochem. 2015;133:452. doi: 10.1111/jnc.13022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13022</ArticleId><ArticleId IdType="pmc">PMC4397187</ArticleId><ArticleId IdType="pubmed">25557022</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis PP, et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol. 2011;11:46. doi: 10.1186/1472-6750-11-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6750-11-46</ArticleId><ArticleId IdType="pmc">PMC3103428</ArticleId><ArticleId IdType="pubmed">21549012</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. Elegant graphics for data analysis: ggplot2. Appl. Spatial Data Anal. R. 2018 doi: 10.1007/978-0-387-78171-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-78171-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, et al. IFN-gamma promotes tau phosphorylation without affecting mature tangles. FASEB J. 2015;29:4384. doi: 10.1096/fj.15-275834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.15-275834</ArticleId><ArticleId IdType="pmc">PMC6137542</ArticleId><ArticleId IdType="pubmed">26156074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>